Epilepsy Market Research Reports & Industry Analysis
Epilepsy Industry Research & Market Reports
-
Middle East & Africa Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Middle East & Africa epilepsy market was valued at US$ 456.34 million ... Read More
-
Asia Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Asia Pacific epilepsy market was valued at US$ 2,200.92 million in 2022 and is ... Read More
-
Bioelectric Medicine Market Research Report Information by Type (Implantable Electroceutical Devices and Non-invasive Electroceutical Devices), by Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, And Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Epilepsy, And Others), By End User (Hospitals & Clinics, ASCs, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2030
... Substance Abuse Disorder, Schizophrenia, and Other Mental Disorder] and Behavioral Disorder [Attention Deficit Hyperactivity Disorder (ADHD), Emotional Behavioral Disorder, Oppositional Defiant Disorder, Obsessive Compulsive Disorder (OCD), and Other Behavioral Disorder]), by Age Group (Children & ... Read More
-
Global Anti Epilepsy Drugs Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the ... Read More
-
Anti Epilepsy Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2034
... Syndrome in the US were ~50,090. In 2023, the total diagnosed prevalent cases of Early Myoclonic Encephalopathy in Japan were around 20, where as the diagnosed prevalent cases of Epileptic Encephalopathy with continuous spike-and-wave during ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2034
... which is expected to grow at a CAGR of ~40% during the forecast period (2020-2034). Among EU4 and the UK, Germany will capture the maximum revenue share, followed by Italy in 2034. In the 7MM, ... Read More
-
Global Pediatric Home Healthcare Market Size Study, by Services (Skilled Nursing Services, Personal Care Assistance, Rehabilitation Therapy Services), by Application (Cancer, Respiratory Disease, Cardiovascular Disease, Physical Disabilities, Others), and Regional Forecasts 2022-2032
... Healthcare Market is valued at USD 39.69 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2024-2032. Pediatric home healthcare is a comprehensive, ... Read More
-
Epilepsy Drugs Market Report and Forecast 2024-2032
... a CAGR of 4.40% during the forecast period of 2024-2032, driven by the continuous advancements in drug development. The market is experiencing robust growth and is expected to reach USD 12 billion by 2032. Global ... Read More
-
Epilepsy Drugs Global Market Report 2024
... Intra-Muscular4) By Distribution Channel: Drug Stores And Retail Pharmacies; Hospital PharmaciesCovering: Pfizer Inc; SK Biopharmaceuticals; Sanofi; Abbott Laboratories; Novartis AG Epilepsy Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Global Brain Imaging Devices Market Size study, by Product (Devices, Accessories) by Application (Stroke, Brain Tumor, Traumatic brain injury (TBI), Epilepsy, Sleep Apnea, Headache, Structural anomalies, Other Applications) by Modality (Fixed, Portable, W
... Use (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers, Other End-users) and Regional Forecasts 2022-2032 Global Brain Imaging Devices Market is valued approximately USD 5.26 billion in 2023 and is anticipated to grow with a growth ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Neurostimulation Devices Market Report by Stimulation Type (Internal Stimulation, External Stimulation), Device Type (SCS (Spinal Cord Stimulation) Devices, DBS (Deep Brain Stimulation) Devices, SNS (Sacral Nerve Stimulation) Devices, VNS (Vagus Nerve Stimulation) Devices, GES (Gastric Electrical Stimulation) Devices, Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, and Others), Application (Pain Management, Epilepsy, Essential Tremors, Urinary and Fecal Incontinence, Depression, Dystonia, Parkinson’s Disease, and Others), End-User (Rehabilitation Centers, Hospitals, Medical Clinics, and Others), and Region 2024-2032
... Electrical Stimulation) Devices, Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, and Others), Application (Pain Management, Epilepsy, Essential Tremors, Urinary and Fecal Incontinence, Depression, Dystonia, Parkinson’s Disease, and Others), End-User (Rehabilitation Centers, Hospitals, Medical ... Read More
-
Neuromodulation Market Report by Technology (Internal Neuromodulation, External Neuromodulation), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Others), and Region 2024-2032
... US$ 7.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The market is experiencing robust growth, driven ... Read More
-
Global Deep Brain Stimulation Market: Analysis By Product (Dual Channel and Single Channel), By Application (Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy and Others), By End Use (Hospitals, Neurology Clinics, Ambulatory Surgical Clinics and Research Centers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2023 Base Year 2023 Forecast Period 2024-2029 Page Count 153 Units Referenced US ... Read More
-
Global Anti Epilepsy Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 4130.1 million by 2030 with a CAGR of 2.0% during review period. Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, ... Read More
-
Global Epilepsy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 5939.7 million by 2030 with a CAGR of 2.8% during review period. Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory ... Read More
-
Global Dravet Syndrome Treatment Market 2024-2028
... dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Electroceutical Bioelectric Medicine Market 2024-2028
... electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Drug Resistant Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Drug Resistant Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Drug Resistant Epilepsy market report provides current ... Read More
-
KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE), historical and forecasted epidemiology as well as the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Partial Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Partial Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Partial Epilepsy market report provides current treatment practices, emerging drugs, Partial ... Read More
-
Global Epilepsy Drugs Market Size study & Forecast, by Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), by Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Regional Analysis, 2023-2030
... is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030. Epilepsy is a neurological disorder characterized by ... Read More
-
Refractory Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Refractory Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Refractory Epilepsy market report provides current treatment practices, emerging drugs, Refractory ... Read More
-
Dravet Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Dravet Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dravet Syndrome market report provides current treatment practices, emerging drugs, Dravet ... Read More
Research Assistance
